Point72 Middle East FZE’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,613	Closed	-$724K	–	1295
2023 Q3	$724K	Buy	23,613 +6,629	+39%	+$203K	0.02%	341
2023 Q2	$681K	Buy	+16,984	New	+$681K	0.02%	363
2023 Q1	–	Sell	-11,622	Closed	-$449K	–	1497
2022 Q4	$449K	Buy	+11,622	New	+$449K	0.02%	412